Table of Contents
ISRN Neurology
Volume 2012 (2012), Article ID 786526, 6 pages
http://dx.doi.org/10.5402/2012/786526
Clinical Study

Quality of Life Assessment in Patients with Multiple Sclerosis Receiving Interferon Beta-1a: A Comparative Longitudinal Study of Avonex and Its Biosimilar CinnoVex

1Neurology Department, Amiralam Hospital, Tehran University of Medical Sciences, Tehran 1145765111, Iran
2Islamic Azad University, Tehran, Iran
3Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Received 12 June 2012; Accepted 2 July 2012

Academic Editors: P. Annunziata, B. Moreno-López, and Y. Ohyagi

Copyright © 2012 R. Abolfazli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

R. Abolfazli, A. Hosseini, Kh. Gholami, M. R. Javadi, H. Torkamandi, and S. Emami, “Quality of Life Assessment in Patients with Multiple Sclerosis Receiving Interferon Beta-1a: A Comparative Longitudinal Study of Avonex and Its Biosimilar CinnoVex,” ISRN Neurology, vol. 2012, Article ID 786526, 6 pages, 2012. doi:10.5402/2012/786526